Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Arab Pesticides & Veterinary Drugs Manufacturing Co Debt-to-Asset Chart
The Arab Pesticides & Veterinary Drugs Manufacturing Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Arab Pesticides & Veterinary Drugs Manufacturing Co Debt-to-Asset vs Agriculture Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Arab Pesticides & Veterinary Drugs Manufacturing Co (AMM:MBED) has a Debt-to-Asset of 0.11 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on The Arab Pesticides & Veterinary Drugs Manufacturing Co and its competitors.
Is The Arab Pesticides & Veterinary Drugs Manufacturing Co's Debt-to-Asset too high?
The Arab Pesticides & Veterinary Drugs Manufacturing Co's current Debt-to-Asset is 0.11. Overall, The Arab Pesticides & Veterinary Drugs Manufacturing Co has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does The Arab Pesticides & Veterinary Drugs Manufacturing Co's Debt-to-Asset compare to CTVA and CF?
The Arab Pesticides & Veterinary Drugs Manufacturing Co's Debt-to-Asset of 0.11 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for an Agriculture company?
A good Debt-to-Asset depends on the Agriculture industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on The Arab Pesticides & Veterinary Drugs Manufacturing Co and its competitors. The Arab Pesticides & Veterinary Drugs Manufacturing Co's current Debt-to-Asset is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Arab Pesticides & Veterinary Drugs Manufacturing Co stock overvalued right now?
Based on GuruFocus' analysis, The Arab Pesticides & Veterinary Drugs Manufacturing Co (AMM:MBED) is currently considered Significantly Overvalued. The stock's GF Value™ is JOD2.36, compared to a current price of JOD4.40 — trading 86.4% above its estimated fair value. The current Debt-to-Asset is 0.11. The Arab Pesticides & Veterinary Drugs Manufacturing Co's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For The Arab Pesticides & Veterinary Drugs Manufacturing Co (AMM:MBED), the current Debt-to-Asset is 0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Arab Pesticides & Veterinary Drugs Manufacturing Co (AMM:MBED) Overvalued in 2026?
Based on GuruFocus' analysis, The Arab Pesticides & Veterinary Drugs Manufacturing Co stock appears to be overvalued.
The current stock price of JOD4.40 is trading 86.4% above its estimated GF Value™ of JOD2.36.
GuruFocus considers The Arab Pesticides & Veterinary Drugs Manufacturing Co to be Significantly Overvalued.
Key valuation signals for AMM:MBED:
Debt-to-Asset: 0.11
GF Value™: JOD2.36 vs. price of JOD4.40 (86.4% above fair value)
No single metric tells the full story. See the AMM:MBED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Arab Pesticides & Veterinary Drugs Manufacturing Co is a Jordan based company. It is a generic manufacturer of veterinary drugs and pesticides. The products included among pesticides are insecticides, nematicides, fungicides, and rodenticides, among others; and those among veterinary drugs include antibiotics, ectoparasiticides, and vitamins, among others. Geographically, company distributes in Africa, the Middle East, Southeast Asia, Latin America, and Europe.
87GF Score
Get the complete analysis for AMM:MBED
Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:MBED has been successfully added to your 
